Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Visible Abdominal Distension

Hospital Universitari Vall d'Hebron Research Institute · NCT06369753

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–80 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
100
US sites recruiting
1
Study start
July 30, 2025
Record last updated
October 31, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Background. Abdominal distention is produced by an abnormal somatic postural tone. The authors developed an original biofeedback technique. In a randomized, placebo-controlled trial the authors demonstrated the superiority of biofeedback over placebo for the treatment of abdominal distention. However, the technique is technically complex and unpractical.

Aim. To prove the efficacy of a noninstrumental biofeedback technique, transmitted by a standard training program, for the treatment of abdominal distension in different centers.

Selection criteria. Episodes of visible abdominal distension. Intervention. Patients will be randomized into biofeedback and placebo groups. Three sessions of either biofeedback or placebo intervention will be performed during the first 3 weeks of the intervention period.

Biofeedback: Patients will be taught to control abdominal and thoracic muscular activity by providing instructions using an original video support. In each center one operator will receive a standard training on how to deliver the noninstrumental biofeedback treatment. Patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period.

Placebo: Sham measurements of abdominal and thoracic motion will be performed, and a pill of placebo containing 0.21 g glucose will be administered; patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.

Being studied: Biofeedback; Placebo

Conditions: Irritable Bowel Syndrome; Dyspepsia; Functional Bloating

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • episodes of visible abdominal distension triggered by meal ingestion

Exclusion Criteria

  • organic cause detected by clinical work-up
  • constipation
  • abdominal distension not confirmed by the 7-day clinical questionnaires in the pre- intervention evaluation

Recruiting US locations

  • G. Oppenheimer Center for Neurobiology of Stress and Resilience

    Los Angeles, CA 90095

    Site contact: Lin Chang, M.D. · (310) 206-0192 · LinChang@mednet.ucla.edu

Study contacts (from the official record)

  • Fernando Azpiroz, MD · 34 932746259 · azpiroz.fernando@gmail.com
  • Jordi Serra, MD · 34 932746259 · jordi.serra@vallhebron.cat
Visible Abdominal Distension (NCT06369753) | Bored Studies